和元生物(688238)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

688238 和元生物

已收盘 04-18 15:00:00

{"stockData":{"symbol":"688238","market":"SH","secType":"STK","nameCN":"和元生物","latestPrice":5.68,"timestamp":1744959600000,"preClose":5.59,"halted":0,"volume":18274872,"delay":0,"changeRate":0.0161,"floatShares":641000000,"shares":649000000,"eps":-0.7946,"marketStatus":"已收盘","change":0.09,"latestTime":"04-18 15:00:00","open":5.6,"high":6,"low":5.57,"amount":107000000,"amplitude":0.0769,"askPrice":5.74,"askSize":72,"bidPrice":5.68,"bidSize":1610,"shortable":0,"etf":0,"ttmEps":-0.7946,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1745199000000},"marketStatusCode":5,"adr":0,"adjPreClose":5.59,"symbolType":"stock_kcb","openAndCloseTimeList":[[1744939800000,1744947000000],[1744952400000,1744959600000]],"highLimit":6.15,"lowLimit":5.03,"ibTradeSell":true,"ibTradeBuySell":false,"totalEquity":649036700,"isCdr":false,"pbRate":2.12,"roa":"--","roe":"--","epsLYR":-0.497,"committee":0.361423,"marketValue":3687000000,"turnoverRate":0.0285,"status":0,"nextConnectDate":"根据港交所公布的数据，今日已停止北向交易，下一个交易日为北京时间 2025-04-22。","afterMarket":{"amount":0,"volume":0,"close":5.68,"buyVolume":0,"sellVolume":0,"time":1744961638029,"indexStatus":"已收盘 04-18 15:30:00","preClose":5.59},"floatMarketCap":3642000000},"requestUrl":"/m/hq/s/688238","defaultTab":"news","newsList":[{"id":"2528032148","title":"和元生物截止03月31日股东人数1.22万户，人均持股5.26万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2528032148","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2528032148?lang=zh_cn&edition=full","pubTime":"2025-04-18 15:20","pubTimestamp":1744960805,"startTime":"0","endTime":"0","summary":"和元生物披露公司股东人数最新情况，截止2025年03月31日，公司股东人数为1.22万户，较上期减少319户，环比减少0.99%。在医疗服务行业个股中，和元生物股东户数少于行业平均水平，截至2025年03月31日，医疗服务行业平均股东户数为4.53万户，户均持股市值方面，医疗服务行业A股上市公司户均持股市值为32.57万元，和元生物少于行业平均水平。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250418160238a6bf0841&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250418160238a6bf0841&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688238","BK0216"],"gpt_icon":0},{"id":"2528293917","title":"图解和元生物年报：第四季度单季净利润同比减132.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2528293917","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2528293917?lang=zh_cn&edition=full","pubTime":"2025-04-18 00:56","pubTimestamp":1744908960,"startTime":"0","endTime":"0","summary":"证券之星消息，和元生物2024年年报显示，公司主营收入2.48亿元，同比上升21.16%；归母净利润-3.22亿元，同比下降151.54%；扣非净利润-3.36亿元，同比下降151.53%；其中2024年第四季度，公司单季度主营收入6428.18万元，同比下降5.2%；单季度归母净利润-1.32亿元，同比下降132.32%；单季度扣非净利润-1.36亿元，同比下降146.53%；负债率23.86%，投资收益0.36万元，财务费用39.36万元，毛利率-37.81%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025041800000668.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688238"],"gpt_icon":0},{"id":"2528761798","title":"和元生物04月17日主力净流入440万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2528761798","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2528761798?lang=zh_cn&edition=full","pubTime":"2025-04-17 15:21","pubTimestamp":1744874495,"startTime":"0","endTime":"0","summary":"04月17日, 和元生物股价涨1.82%，报收5.59元，成交金额5599万元，换手率1.56%，振幅4.19%，量比0.54。和元生物今日主力资金净流入440万元，上一交易日主力净流出544万元。该股近5个交易日上涨5.08%，主力资金累计净流出160万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流出3948万元，其中净流出天数为13日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250417162328a45c34cc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250417162328a45c34cc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0216","688238"],"gpt_icon":0},{"id":"2517433243","title":"AI赋能医疗服务企业提质增效，多场景应用覆盖患者全生命诊疗周期","url":"https://stock-news.laohu8.com/highlight/detail?id=2517433243","media":"环球网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517433243?lang=zh_cn&edition=full","pubTime":"2025-03-07 15:32","pubTimestamp":1741332736,"startTime":"0","endTime":"0","summary":"根据国泰君安研报，DeepSeek的突破性技术显著加速AI在医疗行业的应用进程，多场景应用覆盖患者全生命诊疗周期，赋能医疗服务企业提升服务效率和质量，实现降本增效。AI医生能够加速青年医生培养，提升优质医疗资源供给。此外，AI智能助手助力医生在预问诊、电子病历生成和质量控制等方面提升效率。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307153301989f8907&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307153301989f8907&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688710","688238","BK0132","603882","BK0188","BK0060","688621","603259","600763","688046","688073","600568","BK0077","603456","BK0284","603127","688315","688265","688202","688222","688131","BK0139","BK0239","600721"],"gpt_icon":0},{"id":"2517046438","title":"医疗健康行业2024年专利分析白皮书","url":"https://stock-news.laohu8.com/highlight/detail?id=2517046438","media":"知识产权出版社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517046438?lang=zh_cn&edition=full","pubTime":"2025-03-07 00:00","pubTimestamp":1741276800,"startTime":"0","endTime":"0","summary":"本报告从医疗健康行业全球专利竞争态势、支撑技术和业务应用场景等维度进行分析，以期全面了解医疗健康行业专利竞争发展现状。中国医疗健康行业的专利申请数量已超过18.7 万件，占全球总量的51.7%，远超过其他国家。平安集团以4176 件医疗健康行业专利申请位居第一位，飞利浦以微弱差距位居第二，两家企业专利申请量远超其他专利权人，专利优势突出，技术创新实力明显超过其他主体。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307200225a26426e1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307200225a26426e1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["159760","688222","600721","600085","LU0405327494.USD","LU1064131003.USD","LU1969619763.USD","600276","603087","BK0060","BK0196","600332","BK0012","600763","688202","LU1064130708.USD","603882","LU1328615791.USD","688621","LU0405327148.USD","BK0188","688617","600436","600521","688710","603259","688265","688578","603127","BK0239","688046","688073","688271","688278","688315","600079","BK0028","BK0183","603658","600196","688131","LU2328871848.SGD","600161","600568","603456","LU2148510915.USD","600566","600380","688238","LU2488822045.USD"],"gpt_icon":0},{"id":"2517562061","title":"3月6日和元生物发布公告，股东减持90万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2517562061","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517562061?lang=zh_cn&edition=full","pubTime":"2025-03-06 20:00","pubTimestamp":1741262457,"startTime":"0","endTime":"0","summary":"证券之星消息，3月6日和元生物发布公告《和元生物:关于5%以上股东权益变动触及1%的提示性公告》，其股东上海檀英投资合伙企业(有限合伙)于2025年1月1日至2025年3月5日间合计减持90.0万股，占公司目前总股本的0.1387%，变动期间该股股价上涨12.75%，截止3月5日收盘报5.57元。股东增减持详情见下表：根据和元生物2024年三季报公布的十大股东详情如下：以上内容为证券之星据公开信息整理，由智能算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025030600035996.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688238"],"gpt_icon":0},{"id":"2517787155","title":"和元生物股东及其一致行动人累计减持90万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2517787155","media":"财中社","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517787155?lang=zh_cn&edition=full","pubTime":"2025-03-06 19:44","pubTimestamp":1741261461,"startTime":"0","endTime":"0","summary":"3月6日，和元生物发布公告，公告指出其股东上海檀英投资合伙企业及其一致行动人自2025年1月1日至2025年3月5日期间，通过大宗交易方式累计减持公司股份90万股，减持比例占公司当前总股本6.49亿股的0.1387%。此次减持后，上海檀英及其一致行动人合计持有公司股份3850万股，占总股本的比例由6.0701%变动至5.9314%，触及1%的权益变动整数倍。2024年前三季度，和元生物实现收入1.84亿元，归母净利润-1.90亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306194507989e87c4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306194507989e87c4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0216","688238"],"gpt_icon":0},{"id":"2517115390","title":"和元生物(688238.SH)遭股东上海檀英及其一致行动人减持90万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2517115390","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517115390?lang=zh_cn&edition=full","pubTime":"2025-03-06 19:22","pubTimestamp":1741260130,"startTime":"0","endTime":"0","summary":"智通财经APP讯，和元生物(688238.SH)公告，公司收到股东上海檀英及其一致行动人发来的《关于所持和元生物技术(上海)股份有限公司减持股份触及1%告知函》，上海檀英及其一致行动人自2025年1月1日至2025年3月5日期间，累计减持公司股份90万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1258713.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0216","688238"],"gpt_icon":0},{"id":"2517137838","title":"和元生物3月6日现1笔大宗交易 成交金额152.1万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517137838","media":"新浪证券-红岸工作室","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517137838?lang=zh_cn&edition=full","pubTime":"2025-03-06 17:40","pubTimestamp":1741254000,"startTime":"0","endTime":"0","summary":"　　3月6日，和元生物收涨0.72%，收盘价为5.61元，发生1笔大宗交易，合计成交量30万股，成交金额152.1万元。　　进一步统计，近3个月内该股累计发生3笔大宗交易，合计成交金额为605.6万元。该股近5个交易日累计上涨1.08%，主力资金合计净流入1170.94万元。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/ggzz/2025-03-06/doc-inenthxf6666176.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["688238","BK0216"],"gpt_icon":0},{"id":"2517131275","title":"3月6日和元生物现152.1万元大宗交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2517131275","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517131275?lang=zh_cn&edition=full","pubTime":"2025-03-06 17:20","pubTimestamp":1741252832,"startTime":"0","endTime":"0","summary":"证券之星消息，3月6日和元生物发生大宗交易，交易数据如下：大宗交易成交价格5.07元，相对当日收盘价折价9.63%，成交30万股，成交金额152.1万元，买方营业部为浙商证券股份有限公司上海浦东杨高南路证券营业部，卖方营业部为中信建投证券股份有限公司上海市五莲路证券营业部。近三个月该股共发生3笔大宗交易，合计成交1.2万手，折价成交3笔。截至2025年3月6日收盘，和元生物报收于5.61元，上涨0.72%，换手率2.2%，成交量10.29万手，成交额5799.33万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025030600029657.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688238"],"gpt_icon":0},{"id":"2517150672","title":"券商观点|2025年政府工作报告-医药生物行业：更重“医疗质量”，加大创新支持，改革持续深化","url":"https://stock-news.laohu8.com/highlight/detail?id=2517150672","media":"同花顺iNews","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517150672?lang=zh_cn&edition=full","pubTime":"2025-03-06 17:15","pubTimestamp":1741252540,"startTime":"0","endTime":"0","summary":"报告具体内容如下：投资要点 3月5日发布的2025年《政府工作报告》在2025年政府工作任务中提出“建立未来产业投入增长机制，培育生物制造、量子科技、具身智能、6G等未来产业”，生物制造行业有望加速发展。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306171642a26232f6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306171642a26232f6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["159891","603882","BK0188","688265","688046","600763","600721","688073","688202","603259","600568","BK0060","BK0284","603456","BK0132","163118","688131","BK0239","603127","BK0139","BK0077","688621","000808.SH","688222","688238","688315","688710"],"gpt_icon":0},{"id":"2517150674","title":"讯飞星火医疗大模型X1发布，医疗推理能力效果均超GPT-4o、DeepSeek R1","url":"https://stock-news.laohu8.com/highlight/detail?id=2517150674","media":"动脉网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517150674?lang=zh_cn&edition=full","pubTime":"2025-03-06 08:03","pubTimestamp":1741219432,"startTime":"0","endTime":"0","summary":"讯飞医疗近日发布的讯飞星火医疗大模型X1，或给出了当下最好的解法。作为当前唯一采用全国产算力训练的医疗深度推理大模型，星火医疗大模型X1在诊断推荐、健康咨询等医学任务上效果已超过GPT-4o以及DeepSeek R1，个人健康助手讯飞晓医专业性、实用性及个性化也被进一步加强。讯飞星火医疗大模型X1在诊断推荐、健康咨询、检查检验报告解读等推理任务上效果均超过了GPT-4o以及DeepSeek R1，可进一步提升医疗服务质量与患者服务体验，扩大医疗服务供给。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306081214abea5562&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306081214abea5562&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603882","688073","603259","688046","688315","600763","688131","688393","688358","688202","688621","159891","688222","600568","688710","688265","688238","603127","600721","688246","603456"],"gpt_icon":0},{"id":"2517147669","title":"医药生物行业周报：“AI+医疗医药”主题持续发酵，短期热度或有望延续","url":"https://stock-news.laohu8.com/highlight/detail?id=2517147669","media":"国都证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517147669?lang=zh_cn&edition=full","pubTime":"2025-03-05 20:09","pubTimestamp":1741176568,"startTime":"0","endTime":"0","summary":"核心观点一、周报摘要上周医药生物板块上涨2.71%，跑赢沪深300指数，细分板块全部上涨，医疗服务领涨。得益于DeepSeek等国产AI大模型快速发展带来的性能提升和成本下降，“AI+医药/医疗”应用有望加速落地。海外方面，美股医疗AI代表公司之一TempusAI单周涨幅约30%，年内涨幅超160%，持续推动医疗AI概念发酵。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305200932963ab339&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305200932963ab339&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688131","BK0077","000808.SH","688046","688246","159938","BK0060","688222","600763","BK0139","BK0188","BK0239","BK0284","600721","600568","603456","688315","688393","688358","688265","603259","688073","163118","688238","688621","603882","688202","688710","BK0132","159891","603127"],"gpt_icon":0},{"id":"2517399144","title":"和元生物3月5日现1笔大宗交易 成交金额253.5万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517399144","media":"新浪证券-红岸工作室","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517399144?lang=zh_cn&edition=full","pubTime":"2025-03-05 17:41","pubTimestamp":1741167660,"startTime":"0","endTime":"0","summary":"　　3月5日，和元生物收跌1.59%，收盘价为5.57元，发生1笔大宗交易，合计成交量50万股，成交金额253.5万元。　　第1笔成交价格为5.07元，成交50.00万股，成交金额253.50万元，溢价率为-8.98%，买方营业部为国泰君安证券股份有限公司总部，卖方营业部为中信证券股份有限公司上海浦东新区东方路证券营业部。　　进一步统计，近3个月内该股累计发生2笔大宗交易，合计成交金额为453.5万元。该股近5个交易日累计上涨0.00%，主力资金合计净流出577.25万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/ggzz/2025-03-05/doc-inenqxsm4489848.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["688238","BK0216"],"gpt_icon":0},{"id":"2517962659","title":"3月5日和元生物现253.5万元大宗交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2517962659","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517962659?lang=zh_cn&edition=full","pubTime":"2025-03-05 17:20","pubTimestamp":1741166433,"startTime":"0","endTime":"0","summary":"证券之星消息，3月5日和元生物发生大宗交易，交易数据如下：大宗交易成交价格5.07元，相对当日收盘价折价8.98%，成交50万股，成交金额253.5万元，买方营业部为国泰君安证券股份有限公司总部，卖方营业部为中信证券股份有限公司上海浦东新区东方路证券营业部。近三个月该股共发生2笔大宗交易，合计成交9000.0手，折价成交2笔。截至2025年3月5日收盘，和元生物报收于5.57元，下跌1.59%，换手率1.82%，成交量8.49万手，成交额4730.3万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025030500029684.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688238"],"gpt_icon":0},{"id":"2517960052","title":"和元生物03月05日主力净流出20万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2517960052","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517960052?lang=zh_cn&edition=full","pubTime":"2025-03-05 15:21","pubTimestamp":1741159309,"startTime":"0","endTime":"0","summary":"03月05日, 和元生物股价跌1.59%，报收5.57元，成交金额4730万元，换手率1.82%，振幅3.36%，量比0.72。和元生物今日主力资金净流出20万元，上一交易日主力净流入1143万元。|03月05日主力加仓幅度前10个股||#|股票简称|主力净额占比|#|元道通信|9.05%|#|卓翼科技|7.54%|#|祥明智能|5.65%|#|山东矿机|5.17%|#|本川智能|4.90%|#|新力金融|4.81%|#|三维通信|4.55%|#|翔腾新材|4.12%|#|宜安科技|4.11%|#|武汉凡谷|3.91%|和元生物所在的医疗服务行业，今日主力净流出10.98亿元，行业排名6/124。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305163030abe93618&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305163030abe93618&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688238","BK0216"],"gpt_icon":0},{"id":"2517891476","title":"医药行业：AI全面赋能医疗 推动服务升级","url":"https://stock-news.laohu8.com/highlight/detail?id=2517891476","media":"国泰君安证券股...","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517891476?lang=zh_cn&edition=full","pubTime":"2025-03-05 00:00","pubTimestamp":1741104000,"startTime":"0","endTime":"0","summary":"京东健康在2024年7 月推出面向消费者的“康康”AI 健康智能体，可以解答用户健康疑问，且提供精准高效的医疗资源服务链接。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305164652989cde81&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305164652989cde81&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603882","688073","BK0077","603259","688046","BK0284","688315","600763","688131","688393","688358","688202","688621","159891","688222","600568","688710","688265","BK0188","BK0060","688238","603127","600721","BK0239","BK0132","688246","BK0139","603456"],"gpt_icon":0},{"id":"2516678773","title":"和元生物：公司尚未实施本次股份回购","url":"https://stock-news.laohu8.com/highlight/detail?id=2516678773","media":"证券","labels":["buyback"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516678773?lang=zh_cn&edition=full","pubTime":"2025-03-04 19:42","pubTimestamp":1741088520,"startTime":"0","endTime":"0","summary":"证券日报网讯 3月4日晚间，和元生物发布公告称，截至2025年2月28日，公司尚未实施本次股份回购。\n\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2025-03-04/doc-inennyzc9671122.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"buyback","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["688238","BK0216"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1744977033860,"stockEarnings":[{"period":"1week","weight":0.0508},{"period":"1month","weight":-0.0244},{"period":"3month","weight":0.1944},{"period":"6month","weight":0.1316},{"period":"1year","weight":0.0648},{"period":"ytd","weight":0.1316}],"compareEarnings":[{"period":"1week","weight":0.0176},{"period":"1month","weight":-0.0436},{"period":"3month","weight":0.0119},{"period":"6month","weight":0.0058},{"period":"1year","weight":0.068},{"period":"ytd","weight":-0.0213}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"和元生物技术(上海)股份有限公司","boardCode":"AI0073","boardName":"研究和试验发展","stockholders":"12181人(较上一季度减少0.99%)","perCapita":"52634股","listingDate":"2022-03-22","address":"上海市浦东新区国际医学园区紫萍路908弄19号楼","registeredCapital":"64903万元","survey":"　　和元生物技术(上海)股份有限公司是一家聚焦基因治疗领域的生物科技公司，专注于为基因治疗的基础研究提供基因治疗载体研制、基因功能研究等CRO服务，以及为基因药物的研发提供IND-CMC药学研究、临床样品GMP生产等CDMO服务。主要产品有基因治疗CRO、基因治疗CDMO、生物制剂、试剂。","listedPrice":13.23},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.2","shortVersion":"4.33.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"和元生物(688238)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供和元生物(688238)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"和元生物,688238,和元生物股票,和元生物股票老虎,和元生物股票老虎国际,和元生物行情,和元生物股票行情,和元生物股价,和元生物股市,和元生物股票价格,和元生物股票交易,和元生物股票购买,和元生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"和元生物(688238)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供和元生物(688238)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}